Altasciences has over 10 years’ experience in cannabis studies, conducting nearly 40 studies on different cannabis products, cannabinoids, or with cannabis users. We are also at the forefront of comparing vaping devices to combustible products, both for pharmacokinetics and exposure to potential harmful biomarkers. Our studies meet current FDA regulations for tobacco products.
We have extensive experience with all routes of administration:
- Topical gels
We have worked with whole plant extracts and isolated phytocannabinoids or fully synthetic cannabinoids. Our bioanalytical laboratory has validated methods for THC, CBD, and three other cannabinoids, as well as five of the most common terpenes.
We also routinely assess drug-liking as well as psychoactive and cognitive effects of cannabis or cannabinoid formulations.
- Large database of recreational drug users that can be stratified across frequency of prior use
- ~40 studies on cannabis products, cannabinoids, or requiring cannabis users
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.